Mapp Biopharmaceutical Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
73
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$900K
Mapp Biopharmaceutical General Information
Description
Developer of novel pharmaceuticals designed for the prevention and treatment of infectious diseases. The company develops monoclonal antibody-based therapies and prophylactic candidates targeting emerging infectious diseases and biodefense-related health threats, enabling healthcare systems, government agencies, and public health organizations to access medical countermeasures for outbreak preparedness and disease management.
Contact Information
Website
www.mappbio.comCorporate Office
- 4921 Directors Place
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 4921 Directors Place
- Suite 100
- San Diego, CA 92121
- United States
Mapp Biopharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 14-Oct-2022 | $900K | Completed | Clinical Trials - General |
Mapp Biopharmaceutical Comparisons
Industry
Financing
Details
Mapp Biopharmaceutical Competitors (25)
One of Mapp Biopharmaceutical’s 25 competitors is PeproTech, a Corporate Backed or Acquired company based in Cranbury, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PeproTech | Corporate Backed or Acquired | Cranbury, NJ | ||||
| Novavax | Corporation | Gaithersburg, MD | ||||
| Celldex | Formerly VC-backed | Hampton, NJ | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain |
Mapp Biopharmaceutical Signals
Mapp Biopharmaceutical Investments (1)
Mapp Biopharmaceutical’s most recent deal was a Joint Venture with Monoclonal Antibody Drugs for Hemorrhagic Fever Viruses (Defyrus / Mapp Biopharmaceutical). The deal was made on 29-Jul-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Monoclonal Antibody Drugs for Hemorrhagic Fever Viruses (Defyrus / Mapp Biopharmaceutical) | 29-Jul-2013 | Joint Venture | Buildings and Property |
Mapp Biopharmaceutical FAQs
-
When was Mapp Biopharmaceutical founded?
Mapp Biopharmaceutical was founded in 2003.
-
Where is Mapp Biopharmaceutical headquartered?
Mapp Biopharmaceutical is headquartered in San Diego, CA.
-
What is the size of Mapp Biopharmaceutical?
Mapp Biopharmaceutical has 73 total employees.
-
What industry is Mapp Biopharmaceutical in?
Mapp Biopharmaceutical’s primary industry is Drug Discovery.
-
Is Mapp Biopharmaceutical a private or public company?
Mapp Biopharmaceutical is a Private company.
-
What is Mapp Biopharmaceutical’s current revenue?
The current revenue for Mapp Biopharmaceutical is .
-
How much funding has Mapp Biopharmaceutical raised over time?
Mapp Biopharmaceutical has raised $900K.
-
Who are Mapp Biopharmaceutical’s competitors?
PeproTech, Novavax, Celldex, BPS Bioscience, and Ability Pharma are some of the 25 competitors of Mapp Biopharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process